Puma Biotechnology (PBYI)
(Delayed Data from NSDQ)
$4.65 USD
-0.29 (-5.87%)
Updated May 15, 2024 04:00 PM ET
After-Market: $4.67 +0.02 (0.43%) 5:50 PM ET
3-Hold of 5 3
A Value B Growth F Momentum B VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
08/01/2024
Time: -- |
6/2024 | $0.01 | -900.00% |
Earnings Summary
For their last quarter, Puma Biotechnology (PBYI) reported earnings of -$0.05 per share, beating the Zacks Consensus Estimate of $-0.16 per share. This reflects a positive earnings surprise of 68.75%. Look out for PBYI's next earnings release expected on August 01, 2024. For the next earning release, we expect the company to report earnings of $0.01 per share, reflecting a year-over-year decrease of 90%.
Earnings History
Price & Consensus
Zacks News for PBYI
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
PBYI: What are Zacks experts saying now?
Zacks Private Portfolio Services